lapatinib has been researched along with ellipticine in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (ellipticine) | Trials (ellipticine) | Recent Studies (post-2010) (ellipticine) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 454 | 0 | 178 |
| Protein | Taxonomy | lapatinib (IC50) | ellipticine (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.0193 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.2 | |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | 3.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y; Xu, Z; Zhao, SJ | 1 |
1 review(s) available for lapatinib and ellipticine
| Article | Year |
|---|---|
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2019 |